Kenneth G. Saag, MD, MSc, discussed the management of premenopausal bone loss and Nancy E. Lane, MD, reviewed clinical data and evidence-based support for the use of vitamin D and calcium supplementation in osteoporosis.
Dusan Bogunovic, PhD, described the latest immune profile findings in MIS-C and Qian Zhang, MD, discussed type I interferon response in severe COVID-19 during a basic science session at ACR Convergence.
NORM President Nancy Ellis, BA, MBA, MHA, shared member survey results in an update on the operational challenges of delivering patient care as practice managers look beyond the pandemic.
Beth Jonas, MD, Gail Kerr, MD, FRCP, and Ronald Anderson, MD, shared their personal insights and described essential skills of ‘master clinicians’ during a candid conversation at ACR Convergence 2021.
Gerd Burmester, MD, discussed evolving research into the pathogenesis of rheumatoid arthritis and outlined sequential steps to reduce the risk of developing the disease.
Aimee Hersh, MD, described the need for additional research into childhood lupus and efforts to create a collaborative research blueprint to better define the disease.
Lupus has a simple definition that belies the complexity of the disease and the challenge of finding effective treatments for it, according to Virginia Pascual, MD.
Peter Grayson, MD, MSc, and Raashid Luqmani, MBBS, DM, FRCP, provided an overview of the new ACR/EULAR classification criteria for vasculitis, the ACR’s first update to the classification criteria for vasculitis since 1990.
Of the six late-breaking abstracts presented at ACR Convergence 2021, three highlighted the importance of COVID-19 vaccination and booster shots for immunocompromised patients.
Investigators presented findings from six significant studies, including the JUNIPERA trial, during Plenary III on Monday, Nov. 8.